China Money Network
Login
Join

Tumor Immunology Biotech Firm Virongin Raises $62M

  • September 21, 2020 — 22:31 CST

This Data Is Locked!

This area is available only to Subscribers.

Virongin, a Chinese biotech firm, has recently completed a US$62 million series C financing. This round of financing was jointly led by CDH Investment and... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: